• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Amorphous Solid Dispersions for Bioavailability Enhancement

    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success

    Manufacturing Dietary Supplements in Economic Uncertainty

    2023 Contract Manufacturing Survey

    New Possibilities for Small Batch Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories

    Vantage Nutrition Acquires ComboCap

    Secarna, SciNeuro Enter Research Agreement for CNS Diseases

    BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines

    Codiak BioSciences to File for Chapter 11
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    PharmaBlock Opens New R&D Facility in Pennsylvania

    Macfarlan Smith Annan Facility Marked for Closure  

    Northwest Bio, Advent BioServices Gain MHRA License for Commercial Manufacturing

    Willow, Suanfarma Complete Manufacturing Process for Cannabigerol

    Harm Reduction Therapeutics, Catalent Ink Naloxone Commercial Supply Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Adare Pharma Solutions Chooses Vantage to Lead Packaging Facility Upgrade

    This is Sofgen Pharmaceuticals

    Why Sofgen Pharmaceuticals?

    Stevanato, Recipharm Partner to Develop Pre-fillable Syringes for Soft Mist Inhaler

    Chewgels™ - An Explosive Experience with Innovative Technology
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories

    Secarna, SciNeuro Enter Research Agreement for CNS Diseases

    Pharming Gets FDA Nod for Joenja

    PharmaBlock Opens New R&D Facility in Pennsylvania

    Catalent Licenses Formulation Technology to Deliver High-Concentration Biologics
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Grand River Aseptic Manufacturing Receives Zero Observations from FDA Inspection

    Sofgen's Center for Pharmaceutical Excellence (CPhE)

    Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success

    What Does the Future of Gene Therapy Hold?

    Automated Regulatory Electronic Publishing: How is It Changing the Industry?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    Societal CDMO

    Almac Group

    Syngene International Ltd.

    TaiMed Biologics
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    Societal CDMO

    Almac Group

    Syngene International Ltd.

    TaiMed Biologics
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility

    Phase I investment of $100 million supports a new three-story manufacturing facility.

    Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility
    Nexus Pharmaceuticals Manufacturing Facility in Pleasant Prairie, WI. (Photo: Business Wire)
    07.29.21
    Nexus Pharmaceuticals, a U.S.-based healthcare company and domestic pharmaceutical manufacturer, recently opened Project Tomorrow—the company’s new, state-of-the-art manufacturing facility in Pleasant Prairie, WI. Wisconsin Governor Tony Evers and U.S. Representative Bryan Steil (WI-01) attended the Project Tomorrow grand opening event.
     
    “Today marks another milestone in our company’s continued mission to manufacture specialty and generic injectables right here in America,” said Mariam S. Darsot, CEO and president, Nexus Pharmaceuticals. “By investing in this new, state-of-the-art facility, Nexus has greatly expanded our capability to deliver dependable, life-saving treatments to millions of patients in need.”
     
    The Phase I investment of $100 million supports a new, three-story manufacturing facility with cutting-edge technology, including an advanced isolator system and multiple lyophilization (freeze-drying) machines for maximum product protection and sterility. Construction of the facility began in August 2019 and was completed in 2021, with commercial production expected to commence in 2022. The construction and design of the building features eco-friendly green equipment and processes. The full, multi-phase project is expected to be completed in ten years, with an estimated total investment of $250 million.
     
    Earlier this year, Nexus announced that it was ready to serve and support any efforts to increase vaccine manufacturing as a result of the Covid-19 pandemic. Due to the brand-new manufacturing capacity of the facility, Nexus would be able to maintain the production of existing products and simultaneously begin manufacturing vaccines, unlike other veteran drug manufacturers, which may have to sacrifice the production of one critical-need drug for another.
     
    “Thank you to Nexus for choosing Wisconsin to build this incredible, state-of-the-art facility,” said Wisconsin Governor Tony Evers. “This new facility will bring with it the innovation that fosters long-term, economic success. Nexus stands ready to support global COVID-19 vaccine production—a capability that will be boosted as a result of this new manufacturing facility. Not only is Nexus committed to manufacturing quality, safe medicines, but they are also committed to creating the kinds of high-quality jobs that ensure the health and prosperity of families and communities throughout Wisconsin.”
     
    U.S. Representative Bryan Steil, said, “One lesson we have all learned in the last year is the importance of a domestic supply of pharmaceuticals and other critical health care products. This new facility represents an incredible investment not just in Wisconsin, but in Nexus’ commitment to providing life-saving medicines manufactured right here in America.”
     
    The facility is expected to bring over 77 new jobs in a variety of job functions in fields of high-tech manufacturing and science by 2022, creating more than 400 new local jobs long-term. To meet these needs, Nexus plans to partner with local institutions to provide job training and career and research opportunities.
    Suggested For You
    Lyophilization Technology, Inc. Lyophilization Technology, Inc.
    Stiris Research Inc. Stiris Research Inc.
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    CuriRx Launches CuriLytics Platform for Biotherapeutic Development CuriRx Launches CuriLytics Platform for Biotherapeutic Development
    Vaccine Developer Intravacc Adopts Hybrid Business Model Vaccine Developer Intravacc Adopts Hybrid Business Model
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
    Symbiosis Completes Successful MHRA Audit Symbiosis Completes Successful MHRA Audit
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Lakes BioScience Signs Agreement with Cytvia Lakes BioScience Signs Agreement with Cytvia
    UK Govt. Terminates Valneva COVID Vax Agreement UK Govt. Terminates Valneva COVID Vax Agreement
    COVID Booster Vaccines: What’s Next for FDA COVID Booster Vaccines: What’s Next for FDA
    The Future of Clinical Trials The Future of Clinical Trials
    Gaston Salinas Botanical Solution Inc. Gaston Salinas Botanical Solution Inc.
    How to Speed Up Vaccine Development and Production With Genetic Vaccine Technology How to Speed Up Vaccine Development and Production With Genetic Vaccine Technology

    Related Buyers Guide Companies

    • Formulation Development | Lyophilization
      Lyophilization Technology, Inc.

      Lyophilization Technology, Inc.

      ...
      Robin A Jenkins, Administrative Assistant 11.23.22

    • Stiris Research Inc.

      ...
      Denise Palmer, Manager, Business Development 11.04.22

    • Breaking News | Clinical Trials
      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
      09.22.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
      Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate

      Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate

      Will initiate the GMP manufacturing of the clinical batches of FluGen’s M2SR influenza vaccine candidate for upcoming clinical trials.
      09.21.21

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      CuriRx Launches CuriLytics Platform for Biotherapeutic Development

      CuriRx Launches CuriLytics Platform for Biotherapeutic Development

      To provide CMC analytical services to support complex biotherapeutic development using high resolution mass spectrometry.
      09.21.21

    Loading, Please Wait..
    Trending
    • Merck KGaA Secures Exclusive Worldwide Rights To Bavencio
    • Codiak BioSciences To File For Chapter 11
    • BioNTech Revenues Slide With Waning Demand For COVID-19 Vaccines
    • How Industry 5.0 Might Benefit Pharmaceutical Manufacturing
    • Jubilant HollisterStier Appoints Chris Preti President
    Breaking News
    • Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
    • Vantage Nutrition Acquires ComboCap
    • Secarna, SciNeuro Enter Research Agreement for CNS Diseases
    • BioNTech Revenues Slide with Waning Demand for COVID-19 Vaccines
    • Codiak BioSciences to File for Chapter 11
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Amorphous Solid Dispersions for Bioavailability Enhancement
    • Dietary Supplement Quality Assurance Programs Critical to Natural Products Industry Success
    • Manufacturing Dietary Supplements in Economic Uncertainty
    • 2023 Contract Manufacturing Survey
    • New Possibilities for Small Batch Manufacturing
    • Supply Chain Risk Management
    • 3 Ways Pharma Can Outsmart Talent Challenges in 2023
    • Nutraceutical Dosage Trends: Functional Gummies Offer Alternative to Tablets and Capsules
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Melodea Launches New Plastic-Free Packaging Solution
    GOED and NASC Announce Strategic Partnership
    NPA: ‘Major Victory’ in Colorado After Amendment to Eating Disorder Bill
    Coatings World

    Latest Breaking News From Coatings World

    HOFFMANN MINERAL to Focus on Comprehensive Sustainability Strategy
    HMG and Prodrive Renew Technical Partnership
    Eastern Coatings Show Sets Schedule for Technical Papers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs FemDx Medsystems' FalloView Device
    FDA Clears NeuroRPM Parkinson's Disease Monitoring Tech
    Vaporox Earns FDA Nod for VHT-200 Wound Care Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Adragos Pharma Acquires Clinigen's Development Unit, Lamda Laboratories
    Vantage Nutrition Acquires ComboCap
    Secarna, SciNeuro Enter Research Agreement for CNS Diseases
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Thread Beauty Expands Cosmetics Line at Target
    The Body Shop Expands its Refill Program in Canada
    Clinique Introduces Digital Retail Concept—Clinique Lab
    Happi

    Latest Breaking News From Happi

    Arbonne Welcomes New Executives
    Total Sales for Naples Soap Company in 2022 Increase 2% Despite Inflation, Supply Chain Issues
    IBA Supports FDA in the MoCRA Rulemaking and Implementation Process
    Ink World

    Latest Breaking News From Ink World

    hubergroup Print Solutions Presents Sustainable Portfolio at PAMEX 2023
    Weekly Recap: Packaging Inks, Toyo Ink Top This Week’s Stories
    Eastern Coatings Show Announces Schedule for Technical Papers
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    eProductivity Software acquires Tharstern Group
    Imageworx details new facility, Avery Dennison tackles recycling and more
    TLMI announces 2022 Eugene Singer Award winners
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Period Care Brand August Launches in Target Stores
    Albany International Announced CEO Succession Plan
    Ahlström Partners to Make Sustainable Butter, Margarine Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Exactech Boosts AI Expertise with Licensing Deal, Team of Scientists
    Anchor Harvey Celebrates 100th Anniversary in 2023
    Arjun Ishwar Joins Miach Orthopaedics as Sales and Marketing VP
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Honored with Supplier of the Year 2022 Award by Hyundai Motor Group 
    Weekly Recap: Dave Rahami, Zebra, Dracula Technologies Top This Week’s Stories
    Midsummer, UCLA Collaborate on Perovskite-CIGS Tandem Solar Cells

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login